Panolos Bioscience
PrivateLast Round
Grant
May 20, 2024
Est. Valuation
$80.44M
Total Funding Raised
$28.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Panolos Bioscience is a biopharmaceutical company that develops multi-specific therapeutics for cancer, autoimmune, and rare diseases using its proprietary αART protein design technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panolos Bioscience Comparables
Compare Panolos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novelty Nobility Inc. | 81% | |
| Kanaph Therapeutics | 78% | |
| ABL Bio, Inc. | 76% |
Panolos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2024 | ||||
| Series A | May 17, 2021 | ||||
| Pre Seed | Sep 1, 2020 | ||||
| Angel | Feb 1, 2020 |
Key People
Founding team and executive leadership
Panolos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series A |
| JL Partners | Series A |
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 90% MoM.
- May 16, 2026
Monthly visitors grew 732% MoM, reaching 1.2K.
Panolos Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Panolos Bioscience's valuation, stock price, and market status.
Is Panolos Bioscience a public or private company?
Panolos Bioscience is a private company.
What is the current stock price of Panolos Bioscience?
Panolos Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Panolos Bioscience worth (valuation)?
Panolos Bioscience's valuation is estimated at $80.2M based on funding round data.
Can I buy Panolos Bioscience stock?
Panolos Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panolos Bioscience's last funding round?
Panolos Bioscience's most recent funding round was Grant on May 17, 2021.
Who are the main investors in Panolos Bioscience?
Key investors in Panolos Bioscience include UTC Investment, JL Partners, Government of South Korea.
Will Panolos Bioscience IPO soon?
No public IPO plans have been announced for Panolos Bioscience.
How can I track Panolos Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panolos Bioscience's secondary market activity and sign up for updates.